Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer

INTRODUCTION: For several years non-small cell lung cancer (NSCLC) has been considered non-immunogenic. Recent advances in antitumor immunity brought to the discovery of checkpoints that modulate immune response against cancer. One of them is programmed death receptor 1 (PD-1) and its ligand (PD-L1)...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Arcangelo, Manolo, D’Incecco, Armida, Ligorio, Claudia, Damiani, Stefania, Puccetti, Maurizio, Bravaccini, Sara, Terracciano, Luigi, Bennati, Chiara, Minuti, Gabriele, Vecchiarelli, Silvia, Landi, Lorenza, Milesi, Marina, Meroni, Alberto, Ravaioli, Sara, Tumedei, Maria Maddalena, Incarbone, Matteo, Cappuzzo, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355175/
https://www.ncbi.nlm.nih.gov/pubmed/30728907
http://dx.doi.org/10.18632/oncotarget.26529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355175/
https://www.ncbi.nlm.nih.gov/pubmed/30728907
http://dx.doi.org/10.18632/oncotarget.26529

Ejemplares similares